J Asthma Allergy Clin Immunol.  2002 Jun;22(2):487-493.

A case of Churg-Strauss syndrome in association with leukotriene modifier therapy when oral corticosteroids were withdrawn in an asthmatic patient

Affiliations
  • 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • 2Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea.
  • 3Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • 4Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.

Abstract

Churg-Strauss syndrome is one of idiopathic, systemic necrotizing vasculitis characterized by a history of asthma or allergic rhinitis, eosinophilia of peripheral blood and variable symptoms of systemic vasculitis. There have been several recent case reports of Churg-Strauss syndrome in association with leukotriene modifier therapy when oral corticosteroids were withdrawn in asthmatic patients. We report a case of a 31-year-old man with steroid-dependent asthma who developed Churg-Strauss syndrome after 9 months of steroid withdrawal period, while he was receiving leukotriene modifier (Pranlukast).

Keyword

Churg-Strauss syndrome; asthma; leukotriene antagonist

MeSH Terms

Adrenal Cortex Hormones*
Adult
Asthma
Churg-Strauss Syndrome*
Eosinophilia
Humans
Rhinitis
Systemic Vasculitis
Vasculitis
Adrenal Cortex Hormones
Full Text Links
  • JAACI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr